![The evolution of non-motor symptoms in patients with Parkinson's disease treated with Duodopa intestinal gel Natalia Pritcan Doctor Jozsef Attila Szasz. - ppt download The evolution of non-motor symptoms in patients with Parkinson's disease treated with Duodopa intestinal gel Natalia Pritcan Doctor Jozsef Attila Szasz. - ppt download](https://images.slideplayer.com/26/8737924/slides/slide_4.jpg)
The evolution of non-motor symptoms in patients with Parkinson's disease treated with Duodopa intestinal gel Natalia Pritcan Doctor Jozsef Attila Szasz. - ppt download
![Figure 2 from [Duodopa pump treatment in patients with advanced Parkinson's disease]. | Semantic Scholar Figure 2 from [Duodopa pump treatment in patients with advanced Parkinson's disease]. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1f9afcf51e619eac74aab225843ee0c74a3a7c6e/2-Figure1-1.png)
Figure 2 from [Duodopa pump treatment in patients with advanced Parkinson's disease]. | Semantic Scholar
![The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review | SpringerLink The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-021-01747-1/MediaObjects/12325_2021_1747_Figa_HTML.png)
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review | SpringerLink
![Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa | Neurodegenerative Disease Management Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa | Neurodegenerative Disease Management](https://www.futuremedicine.com/cms/10.2217/nmt-2016-0011/asset/images/medium/figure3.gif)
Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa | Neurodegenerative Disease Management
![Figure 2 from [Duodopa pump treatment in patients with advanced Parkinson's disease]. | Semantic Scholar Figure 2 from [Duodopa pump treatment in patients with advanced Parkinson's disease]. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1f9afcf51e619eac74aab225843ee0c74a3a7c6e/2-Figure2-1.png)
Figure 2 from [Duodopa pump treatment in patients with advanced Parkinson's disease]. | Semantic Scholar
![Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnpjparkd.2016.23/MediaObjects/41531_2016_Article_BFnpjparkd201623_Fig4_HTML.jpg)
Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease
![When the going gets tough: how to select patients with Parkinson's disease for advanced therapies | Practical Neurology When the going gets tough: how to select patients with Parkinson's disease for advanced therapies | Practical Neurology](https://pn.bmj.com/content/practneurol/13/3/140/F4.large.jpg)
When the going gets tough: how to select patients with Parkinson's disease for advanced therapies | Practical Neurology
![Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States | SpringerLink Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-019-01014-4/MediaObjects/12325_2019_1014_Fig1_HTML.png)